Latest news with #Methadone
Time Business News
22-07-2025
- Health
- Time Business News
Medication-Assisted Treatment (MAT): What You Need to Know
Introduction to Medication-Assisted Treatment (MAT) Medication-Assisted Treatment, often abbreviated as MAT, is a clinically driven strategy for treating substance use disorders that fuses pharmacological intervention with behavioral therapies. It is not a substitute for willpower, nor is it a shortcut to sobriety. Rather, MAT serves as a stabilizing force, restoring neurochemical imbalances caused by chronic substance use. Despite its efficacy, MAT remains enveloped in layers of stigma and misunderstanding. Detractors often mischaracterize it as 'trading one addiction for another,' a notion both scientifically inaccurate and socially damaging. In reality, MAT helps individuals regain control, not lose it. Lingering Scents and Misconceptions Many people wonder whether simply being around the odor of cannabis can lead to a high. The truth is, unless you're in an enclosed, poorly ventilated space with heavy smoke, it's highly unlikely. Passive exposure doesn't provide enough THC—the psychoactive compound—to affect someone significantly. So, while the smell may be strong or even irritating to some, can the smell of weed get you high? Not under normal circumstances. Brief exposure to the scent in public or from a nearby smoker won't result in intoxication, though it might cling to clothing or trigger sensitivity in some individuals. How MAT Works At its core, MAT operates on the principle of neuroregulation—helping the brain adjust to life without the euphoric rush of addictive substances. Medications used in MAT are not designed to induce a high. Instead, they normalize brain chemistry, block the euphoric effects of drugs and alcohol, and relieve physiological cravings. The medications most commonly used include methadone, buprenorphine, and naltrexone for opioid use disorder, and disulfiram, acamprosate, and naltrexone for alcohol use disorder. Each functions uniquely. Some bind to opioid receptors to dull withdrawal symptoms, while others act as antagonists to prevent substances from exerting their effects. MAT for Opioid Use Disorder The opioid epidemic has catalyzed a reevaluation of treatment modalities, with MAT emerging as a cornerstone intervention. Methadone, a full opioid agonist, has been used for decades in tightly regulated settings to reduce withdrawal symptoms and cravings. Buprenorphine, a partial agonist, offers similar benefits with a lower risk of misuse due to its ceiling effect. Naltrexone, distinct from the other two, is an opioid antagonist—it entirely blocks the receptor sites, making it impossible to feel the euphoric effects of opioids. This medication is particularly effective in individuals who have already detoxed and wish to avoid relapse. Comparative studies have consistently shown that MAT significantly reduces the risk of fatal overdose, promotes treatment retention, and enhances social functioning. MAT for Alcohol Use Disorder Although less publicized than opioid-related MAT, medication support for alcohol use disorder has also proven transformative. Naltrexone, used for both alcohol and opioid addiction, reduces the rewarding effects of alcohol consumption. Disulfiram, on the other hand, induces acute sensitivity to alcohol, triggering unpleasant reactions when drinking occurs—a deterrent mechanism. Acamprosate works differently. It aims to stabilize brain activity disrupted by chronic alcohol intake, helping individuals maintain abstinence after detox. These pharmacological tools, when combined with counseling and support, elevate recovery prospects significantly. Benefits and Challenges of MAT The benefits of MAT are multifaceted. It enhances survival rates, reduces illicit drug use and criminal activity, improves birth outcomes among pregnant women with substance use disorders, and increases retention in therapeutic programs. For many, it provides the physiological stability needed to engage fully in behavioral therapies and rebuild their lives. Yet MAT is not without its obstacles. Accessibility remains a pressing issue, especially in rural or underserved areas. Misconceptions continue to circulate, leading some to eschew this life-saving treatment. Additionally, side effects—ranging from mild gastrointestinal issues to mood fluctuations—can deter compliance. Healthcare systems must address these barriers with evidence-based education, policy reform, and increased investment in integrated care models. Regulatory and Clinical Guidelines MAT is governed by a complex web of federal and state regulations. Methadone, for example, is only available through licensed opioid treatment programs (OTPs), while buprenorphine requires a prescribing waiver under the Drug Addiction Treatment Act. Recent legislative shifts, including the removal of the DATA 2000 waiver, are aimed at expanding access. Clinicians must adhere to best practice protocols, including comprehensive assessments, treatment planning, monitoring, and coordination with psychosocial support services. Regular drug screening, patient education, and informed consent are all essential elements of responsible MAT delivery. Integrating MAT into a Holistic Recovery Plan Medication alone is not a panacea. True recovery demands a multi-dimensional approach that addresses not only the biological aspects of addiction but also the emotional, psychological, and social underpinnings. MAT should be integrated with evidence-based behavioral therapies such as Cognitive Behavioral Therapy (CBT), Motivational Interviewing (MI), and peer support systems. Every individual's path to recovery is distinct. Some may require short-term pharmacological support, while others benefit from long-term maintenance. Flexibility, personalization, and compassion are key to successful treatment outcomes. When Small Choices Lead to Bigger Problems Certain lifestyle habits can unknowingly aggravate common health issues. For instance, alcohol consumption may seem harmless during social gatherings, but it can pose unexpected complications. One such concern is that does alcohol make a yeast infection worse—and the answer is yes. Alcohol can disrupt the body's natural balance, weaken the immune system, and feed the growth of Candida due to its sugar content. This creates an ideal environment for yeast to thrive, worsening symptoms like itching, irritation, and discharge. Reducing alcohol intake while managing a yeast infection can support faster recovery and prevent recurring flare-ups. Conclusion Medication-Assisted Treatment is more than a clinical intervention—it is a bridge to recovery, dignity, and restored potential. As science continues to evolve, so too must society's understanding of what it means to heal from addiction. MAT provides a proven path forward, not just for managing symptoms, but for reclaiming lives. By championing a balanced, informed approach, communities can transform stigma into support and resistance into resilience. TIME BUSINESS NEWS
IOL News
25-06-2025
- Politics
- IOL News
MK Party spokesperson Nhlamulo Ndhlela releases lab results amid drug use claims from Floyd Shivambu
MK Party spokesperson Nhlamulo Ndhlela denies drug allegations with medical proof. Image: Itumeleng English / Independent Newspapers The uMkhonto weSizwe Party's national spokesperson, Nhlamulo Ndhlela, has released medical test results which appear to confirm he is free from drugs and alcohol. This follows public allegations by former Secretary-General Floyd Shivambu that he was a user of the substances. Shivambu recently accused Ndhlela of being "a liar, takes drugs, and is always under the influence of alcohol." In response, Ndhlela has categorically denied the claims and refuted the claims by publishing drug and alcohol screening results on his official X account. The test results, issued by certified medical facility Lancet Laboratories, confirm he tested negative for the following substances: Alcohol, Cannabis (THC), Cocaine, Amphetamines (including methamphetamine), Opiates (including heroin, codeine, morphine), Benzodiazepines, Barbiturates, Methadone, Methaqualone and Phencyclidine (PCP). However, IOL reached out to Lancet Laboratories, who said that they could neither deny nor confirm the results. Meanwhile, Shivambu says thousands of people have applied to be volunteers in his National Consultation Team (NCT). "The people come from different political parties, the ANC, DA, EFF and a substantial number from MK Party. It is very senior leaders who occupy various position in government who have pledged solidarity," he told the SABC. Shivambu claimed that Jacob Zuma offered him the leadership position in the party, but he denied. "In the initial discussions when I joined there were discussions by President Zuma that I must be the President of the party which I rejected. I said that would be inappropriate because I had tremendous respect of his leadership." However, speaking to the national broadcaster, Ndhlela accused Shivambu of being arrogant. He dismissed Shivambu's claims of R7 million being siphoned from the party monthly. "Umkhonto WeSizwe is a strong party. It is the fastest growing political party in this country. We are bound to have alien tendencies that are not cultural to the party. This is the case with what we are finding ourselves in from now. He has never raised the issue of the R7 million within the party," Ndhlela claimed. Ndhlela has also formally demanded a public apology and retraction from Shivambu within 48 hours, threatening legal action if the demand is not met. "Our client, Nhlamulo Ndhlela, has been subjected to a vicious campaign of lies and character assassination," his lawyers said in a statement. The legal team outlined specific demands, including a public retraction on Shivambu's X account, pinned for seven days, and an unconditional apology. "Social media cannot be a lawless space where individuals are slandered without consequence. We are preparing to issue summons to identified perpetrators and will seek substantial damages." The lawyers also called on Shivambu to contact eNCA to broadcast a correction, with failure to comply risking further legal action. IOL Politics Get your news on the go, click here to join the IOL News WhatsApp channel.
Scottish Sun
22-06-2025
- Business
- Scottish Sun
Scots anti-drugs charity accepts cash from pharma giant that makes METHADONE
The pharma firms sponsored a job role that was advertised Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A ROW has erupted after it emerged one of Scotland's most prominent anti-drugs charities is taking cash from a firm making methadone. Taxpayer-funded quango the Scottish Drugs Forum (SDF) have been at the forefront of calls for harm reduction methods to solve Scotland's shameful addiction and drug deaths crisis. Sign up for Scottish Sun newsletter Sign up 4 The charity receives cash from firms making Methadone - a heroin substitute Credit: Alamy 4 The Scottish Drugs Forum has been pushing for harm reduction methods to get people off drugs - which include Methadone Credit: Alamy 4 Annemarie Ward, of FAVOR UK (Faces & Voices of Recovery UK), accused the quango of having a "dangerous conflict on interest" Credit: Michael Schofield Such methods include addicts being given methadone - a heroin substitute - which opponents say does nothing to get people real help and recovery and just traps a person in addiction. But it has since emerged the SDF is getting financial backing from two firms producing the drug substitutes at the centre of harm reduction tactics. The charity is getting financial backing by big Pharma firms Ethypharm and Camurus, the Mail on Sunday revealed. Among the several drugs produced by Ethypharm is methoadone, which is given put by the NHS for opioid addiction. While Camurus makes a slow-release heroin substitute called Buvidal, which lasts for up to 28 days. The pharma firms sponsored a job role that was advertised at the SDF. The quango was hiring a content creator and editor to help create their "a peer-led, harm reduction-focused magazine created by and for people who use drugs." It was advertised last year with a salary range of £40,937 to £44,699. But the job role said the whole harm-reduction magazine project is only able to happen because of cash given by the pharmaceutical companies. The advert read: "This new project has been made possible thanks to unrestricted educational grants from Ethypharm and Camurus." Drug fix rooms could be rolled out across Scotland before end of controversial Glasgow pilot The charity has now been accused of having a "dangerous conflict of interest" by taking cash from firms producing the drugs. Veteran drug campaigner Annemarie Ward, who has been leading calls for abstinence-based recovery through her charity FAVOR UK, said: "These companies make their money from the very medications this magazine business model depends on maintaining — not solving — mass dependency. "This is a glaring and dangerous conflict of interest." Methadone has been floated as an answer to solving the drugs crisis for years, yet it has continued to claim lives. In the past five years it has proven responsible for 2,898 fatal overdoses. Scottish Tories shadow drugs minister Annie Wells added: "The source of this quango's funding gives rise to legitimate questions over its advice to the SNP government on drugs policy." The CEO of the Scottish Drugs Forum, Kirsten Horsburgh, said: "Scottish Drugs Forum is open and transparent about all sources of funding. "The vast majority of our funding comes from public bodies. "On occasion, we have received a small percentage of project-specific, unrestricted educational grants from pharmaceutical companies. "This is always under strict conditions that ensure complete independence over the work undertaken, with no influence on its content, conclusions or public messaging."
Scottish Sun
16-06-2025
- Health
- Scottish Sun
Scots con almost dies after bungling jail nurse gave her methadone meant for lag with same first name
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A PRISONER almost died of an overdose after an NHS nurse gave her methadone meant for another lag. The woman, 24, thought to be a non-drug user, is said to have suffered a cardiac arrest due to the devastating mistake at Polmont jail near Falkirk. Sign up for Scottish Sun newsletter Sign up 2 Methadone is a substance that acts on opioid receptors and is primarily used for pain relief and anesthesia. 2 The accidental overdose happened at Polmont nick in Stirlingshire Credit: Michael Schofield - The Sun Glasgow She received life-saving treatment in an ambulance on her way to hospital, a jail insider said. It's claimed the mix-up occurred because the victim had the same first name as another prisoner who it was intended for. Health chiefs have launched a probe to find out how the bungle came about. A source said of Friday's horror at HMP Polmont near Falkirk: 'The girl has been very lucky as that amount of methadone can be fatal — it was a terrible mistake. 'It seems the nurse got the names mixed up and gave the medication to the wrong person. 'Both women apparently have the same name. "One is a drug user and one isn't. 'Once she became unwell an ambulance was called but there was a delay, and on her way to hospital she suffered a cardiac arrest. 'She has been in hospital since. "Basically she was overdosed by the nurse. 'Everyone is talking about it and how bad this is.' Scots gangster Ross Monaghan 'erased' from Spanish pub just days after brutal assassination Methadone is a strong synthetic drug similar to morphine prescribed to heroin users to help wean them off their addiction. It reduces withdrawal symptoms such as shaking, shivering and cravings. However, even a small dose can have devastating effects in those who have never used it. Drugs 'pass time' for Polmont lags POLMONT inmates are turning to drugs to help 'pass the time', we can reveal. Prison inspectors found young lags are getting high when there is 'little to do', with those on remand particularly at risk. Families of cons also told auditors last year of their 'constant worry' over bullying and drug use. One lag said: 'Trips is how you get through it.' Others told inspectors they felt judged and 'treated like a junkie'. According to the NHS, severe reactions include problems breathing and irregular, faster or slower than usual heartbeat. Scottish Tory shadow minister for drugs Annie Wells MSP called the mix-up 'deeply alarming'. She added: 'With drugs already rife behind bars, it is vital prisoners suffering from addiction receive the right support as part of their rehabilitation. 'SNP ministers must guarantee urgent measures to avoid this happening again.' Scottish Labour justice spokeswoman Pauline McNeill said: 'There must be an urgent investigation into this deeply worrying incident. 'Scotland's prisons are stretched to breaking point. "This life-threatening mistake is a reminder of how badly things can go wrong.' The Scottish Prison Service said: 'We do not comment on individuals. "Healthcare is managed by NHS partners and we work closely with them to support those in our care.' NHS Forth Valley said it was also 'unable to comment due to patient confidentiality.' In 2021 it was announced that a drug used in a pilot scheme to help heroin-addicted lags was to be rolled out across Scotland. Inmates receive an injection of Buvidal every 28 days instead of daily methadone tablets. The Scottish Government said it had allocated £4million for the project after 'encouraging feedback' from the trial in jails.
Yahoo
03-06-2025
- Health
- Yahoo
Cause of death released for Redwood City inmate Kyle Harrison
(KRON) — A Redwood City street racer died in jail earlier this year shortly after he was sentenced for his role in causing a crash that left twin girls orphaned. On Monday, the San Mateo County Sheriff's Office released Kyle V. Harrison's cause of death. The county coroner's office determined that Harrison died on March 15 at Maple Street Correctional Facility in Redwood City 'due to toxic effects of three medications,' the sheriff's office wrote. The coroner concluded that the 25-year-old inmate's manner of death was an 'accident' and found Harrison died due to toxic effects of Methadone, Amitriptyline, and Gabapentin. Harrison previously pleaded no contest to engaging in a speed contest and felony vehicular manslaughter for the deaths of Grace Spiridon, and her husband, Gregory Ammen. The couple's 7-year-old daughters 'miraculously' survived the crash on El Camino Real, prosecutors said. In February, Harrison was sentenced to serve eight years in state prison. Court records show that Harrison was slated to be transported from the county jail to a state prison facility in May, but he died in jail before he was transferred. Investigators did not say why Harrison was taking Methadone, a medication typically used to treat opioid use disorder. Amitriptyline is an antidepressant medication. Gabapentin is an anticonvulsive medication that's also used to treat certain types of neural pain. The street race happened on Nov. 4, 2022 in Redwood City. Harrison raced his BMW against a teenager, Cesar Salto Morales, who was driving a Mercedes Benz on El Camino Real. Morales' Mercedes slammed into a Chevrolet Bolt with Spiridon, Ammen, and their two young daughters inside. The parents were killed on impact, while their daughters survived in the backseat. The family was less than 10 minutes away from their San Carlos home. Prosecutors said Harrison fled the scene, and a witness recorded his BMW's license plate number with her cellphone as he was driving away. Police found and arrested Harrison weeks later. After his in-custody death, the San Mateo County District Attorney's Office and San Mateo County Coroner's Office conducted independent investigations into Harrison's cause and manner of death. The DA's investigation is still underway. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
